NEXGEL (NXGL) Revenue & Revenue Breakdown
NEXGEL Revenue Highlights
Latest Revenue (Y)
$4.09M
Latest Revenue (Q)
$1.44M
Main Segment (Y)
Contract Manufacturing
NEXGEL Revenue by Period
NEXGEL Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $4.09M | 99.66% |
2022-12-31 | $2.05M | 32.04% |
2021-12-31 | $1.55M | 130.12% |
2020-12-31 | $674.00K | -6.00% |
2019-12-31 | $717.00K | -67.60% |
2018-12-31 | $2.21M | 11.09% |
2017-12-31 | $1.99M | -7.43% |
2016-12-31 | $2.15M | - |
NEXGEL Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $1.44M | 13.74% |
2024-03-31 | $1.27M | 17.01% |
2023-12-31 | $1.08M | -11.38% |
2023-09-30 | $1.22M | 4.63% |
2023-06-30 | $1.17M | 88.23% |
2023-03-31 | $620.00K | 18.32% |
2022-12-31 | $524.00K | -7.75% |
2022-09-30 | $568.00K | 1.25% |
2022-06-30 | $561.00K | 41.67% |
2022-03-31 | $396.00K | -25.70% |
2021-12-31 | $533.00K | 59.10% |
2021-09-30 | $335.00K | -19.66% |
2021-06-30 | $417.00K | 56.18% |
2021-03-31 | $267.00K | 164.36% |
2020-12-31 | $101.00K | -58.26% |
2020-09-30 | $242.00K | 165.93% |
2020-06-30 | $91.00K | -62.08% |
2020-03-31 | $240.00K | 36.36% |
2019-12-31 | $176.00K | -38.68% |
2019-09-30 | $287.00K | 129.60% |
2019-06-30 | $125.00K | -3.10% |
2019-03-31 | $129.00K | -72.02% |
2018-12-31 | $461.00K | 32.47% |
2018-09-30 | $348.00K | -59.72% |
2018-06-30 | $864.00K | 60.00% |
2018-03-31 | $540.00K | -18.43% |
2017-12-31 | $662.00K | - |
NEXGEL Revenue Breakdown
NEXGEL Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 |
---|---|
Contract Manufacturing | $1.98M |
Other Incomes | $76.00K |
Quarterly Revenue by Product
Product/Service | Jun 24 | Mar 24 |
---|---|---|
Contract Manufacturing | $347.00K | $448.00K |
Other Incomes | $33.00K | $12.00K |
NEXGEL Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
PDEX | Pro-Dex | $53.84M | $14.89M |
DXR | Daxor | $34.59M | $36.35M |
ZJYL | Jin Medical | $19.82M | $9.57M |
AVGR | Avinger | $7.65M | $1.85M |
GMVD | G Medical Innovations | $4.42M | $-128.35K |
NYXH | Nyxoah | $4.30M | $1.22M |
NXGL | NEXGEL | $4.09M | $1.44M |
POAI | Predictive Oncology | $1.78M | $419.65K |
LUCY | Innovative Eyewear | $1.15M | $308.68M |
GCTK | GlucoTrack | - | - |
STSS | Sharps | - | - |
NXGL Revenue FAQ
What is NEXGEL’s yearly revenue?
NEXGEL's yearly revenue for 2023 was $4.09M, representing an increase of 99.66% compared to 2022. The company's yearly revenue for 2022 was $2.05M, representing an increase of 32.04% compared to 2021. NXGL's yearly revenue for 2021 was $1.55M, representing an increase of 130.12% compared to 2020.
What is NEXGEL’s quarterly revenue?
NEXGEL's quarterly revenue for Q2 2024 was $1.44M, a 13.74% increase from the previous quarter (Q1 2024), and a 23.39% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.27M, a 17.01% increase from the previous quarter (Q4 2023), and a 104.19% increase year-over-year (Q1 2023). NXGL's quarterly revenue for Q4 2023 was $1.08M, a -11.38% decrease from the previous quarter (Q3 2023), and a 106.49% increase year-over-year (Q4 2022).
What is NEXGEL’s revenue growth rate?
NEXGEL's revenue growth rate for the last 3 years (2021-2023) was 163.64%, and for the last 5 years (2019-2023) was 470.29%.
What are NEXGEL’s revenue streams?
NEXGEL's revenue streams in c 23 are Contract Manufacturing, and Other Incomes. Contract Manufacturing generated $1.98M in revenue, accounting 96.30% of the company's total revenue Other Incomes generated $76K in revenue, accounting 3.70% of the company's total revenue
What is NEXGEL’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of NEXGEL was Contract Manufacturing. This segment made a revenue of $1.98M, representing 96.30% of the company's total revenue.